Surging or Stalling? Uncovering Strategic Factors Behind Healthcare Company Growth in Indonesia
Author(s): Ferdinan Titus Renaldi, Nadia Asandimitra Haryono
Institution: Universitas Negeri Surabaya
Category: Articles, IJMMU
Topics: R & D Expenditure; Company Size; Operating Cash Flow; Leverage; Sales Growth; Future Performance
Abstract: This study aims to analyze the influence of R&D expenditure, company size, operating cash flow, leverage, and sales growth on the future performance of healthcare sector companies listed on the Indonesia Stock Exchange (IDX) during the 2018–2023 period. A total of 11 companies were selected as samples using a purposive sampling method, resulting in 66 observations over the six-year period. Panel data regression analysis was employed, and the findings indicate that R&D expenditure, company size, and operating cash flow have no significant effect on future performance. In contrast, leverage has a significant negative effect, while sales growth has a significant positive effect on the future performance of healthcare companies.
Article can be downloaded>> https://ijmmu.com/index.php/ijmmu/article/view/7008
About Author
